12 Health Care Stocks Moving In Thursday's Pre-Market Session

 

Gainers

  • Innate Pharma IPHA stock increased by 13.7% to $3.32 during Thursday's pre-market session. The market value of their outstanding shares is at $264.6 million.
  • Longeveron LGVN shares moved upwards by 13.29% to $8.01. The market value of their outstanding shares is at $167.0 million.
  • AnPac Bio-Medical Science ANPC stock moved upwards by 11.83% to $0.7. The market value of their outstanding shares is at $11.4 million.
  • ThermoGenesis Holdings THMO shares moved upwards by 11.66% to $0.69. The market value of their outstanding shares is at $8.2 million.
  • Chemomab Therapeutics CMMB stock moved upwards by 10.81% to $4.2. The market value of their outstanding shares is at $47.8 million. The company's, Q4 earnings came out yesterday.
  • Natera NTRA shares increased by 10.76% to $40.76. The company's market cap stands at $3.8 billion.

 

Losers

  • TherapeuticsMD TXMD shares declined by 20.2% to $0.32 during Thursday's pre-market session. The market value of their outstanding shares is at $135.6 million. As per the press release, Q4 earnings came out today.
  • I-MAB IMAB shares fell 18.57% to $17.5. The company's market cap stands at $1.3 billion.
  • TC BioPharm (Holdings) TCBP shares decreased by 16.67% to $1.15. The company's market cap stands at $32.2 million.
  • Sunshine Biopharma SBFM stock declined by 16.32% to $3.18. The company's market cap stands at $14.2 million.
  • Revelation Biosciences REVB stock fell 14.12% to $1.46. The company's market cap stands at $20.7 million.
  • Zai Lab ZLAB shares fell 12.87% to $34.0. The market value of their outstanding shares is at $3.2 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!